Absci Corporation Profile Avatar - Palmy Investing

Absci Corporation

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of b…

Biotechnology
US, Vancouver [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of ABSI's Analysis
CIK: 1672688 CUSIP: 00091E109 ISIN: US00091E1091 LEI: - UEI: -
Secondary Listings
ABSI has no secondary listings inside our databases.